Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobius Investm. Regulatory News (MMIT)

Share Price Information for Mobius Investm. (MMIT)

Share Price is delayed by 15 minutes
Get Live Data
167.00    -1.00 (-0.60%)
Bid:
166.00
Ask:
170.50
Spread: 4.50 (2.711%)
Market Cap: £109.70m
MMIT Live PriceLast checked at - London Stock Exchange

Intraday Mobius Investm. Share Chart

Directorate Change

5 Mar 2025 07:00

RNS Number : 4314Z
Mobius Investment Trust PLC
05 March 2025
 

5 March 2025

 

Mobius Investment Trust plc

("MMIT" or the "Company")

 

 

Directorate Change

 

Appointment of Director

 

The Board of Mobius Investment Trust plc is pleased to announce the appointment of Diana Dyer Bartlett as an independent non-executive director of the Company, with effect from 17 March 2025.

 

After qualifying as a chartered accountant with Deloitte Haskins & Sells, Diana spent five years in investment banking with Hill Samuel. Since then, she has held a number of executive roles including as finance director of various venture capital and private equity backed businesses and listed companies involved in software, financial services, renewable energy and coal mining. She was also Company Secretary of Tullett Prebon plc and Collins Stewart Tullett plc. She is currently also a non-executive director and audit committee chair of Smithson Investment Trust plc and Mid Wynd International Investment Trust plc as well as senior independent non-executive director and audit and risk committee chair of Schroder British Opportunities Trust plc. Previously, she was a non-executive director and chair of the audit committee of SmartSpace Software plc (October 2013 until May 2021) and Rutherford Health plc (November 2019 until August 2020) as well as a director of Precious Cells International Limited (April 2016 - May 2017).

 

During her appointment as a director of SmartSpace Software plc (formerly known as Coms plc and RedstoneConnect plc), the Coms plc group had trading difficulties and Diana took on an interim role as chief finance officer. Following the departure of the finance director and chief executive officer of Coms plc, Diana became a director of the majority of Coms plc's subsidiaries on 1 March 2015. After the sale of the business and assets of most of the Coms plc's subsidiaries, which comprised its telecommunications division, at the end of May 2015 and the discharge of agreed trading liabilities, the following companies were put into creditors' voluntary liquidation: Coms Carrier Services Limited, Network Resource Limited, CloudXL Networks Limited, Coms Mobile Limited, System Online Limited, CloudXL Support Limited, Network Resource Group Limited, Smarter Mobile UK Limited, Coms.com Limited, Premium O Limited, and CloudXL Limited.

 

Diana resigned from her role as a director of Precious Cells International Limited and its subsidiary, Pharmacells Limited on 31 May 2017. The companies were placed into administration on 28 March 2018 and 13 April 2018 respectively.

 

There is no further information to be disclosed under UK Listing Rule 6.4.8(R).

 

Diana has also been appointed to the Company's Audit Committee and Management Engagement and Remuneration Committee and will become Chair of the Audit Committee on Christopher Casey's resignation at the Company's forthcoming Annual General Meeting (see below).

 

Maria Luisa Cicognani commented:

 

"My fellow directors and I are delighted to welcome Diana to the Board. We are very pleased to have appointed a director with extensive industry, financial and audit expertise. Diana will be a great addition to our team, and she will bring a wealth of experience in the sector and listed and private companies."

 

Resignation of Director

 

The Board of Mobius Investment Trust plc also announces that Christopher Casey will resign from his non-executive directorship of the Company and the role of Chairman of the Audit Committee with effect from the close of business of the Company's forthcoming Annual General Meeting on 15 May 2025.

 

Christopher has been an independent member of the Board since the Company's launch in 2018 and will be stepping down as part of MMIT's succession planning efforts. The Board thanks Christopher for his support during these years and his contribution to the Company.

 

 

- ENDS-

 

For further information please contact:

 

Kerstin Rucht

Frostrow Capital LLP

Company Secretary

020 3709 8732

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUWGWUPAUQA
Date   Source Headline
8th Jun 20261:07 pmRNSNet Asset Value(s)
5th Jun 20261:24 pmRNSNet Asset Value(s)
4th Jun 20263:05 pmRNSNet Asset Value(s)
3rd Jun 20261:21 pmRNSNet Asset Value(s)
2nd Jun 20261:49 pmRNSNet Asset Value(s)
1st Jun 20262:24 pmRNSNet Asset Value(s)
29th May 20262:30 pmRNSNet Asset Value(s)
28th May 20262:19 pmRNSNet Asset Value(s)
27th May 20262:35 pmRNSNet Asset Value(s)
26th May 20264:30 pmRNSNet Asset Value(s)
26th May 20261:06 pmRNSCompany Secretary Change
22nd May 20261:03 pmRNSNet Asset Value(s)
21st May 20261:25 pmRNSNet Asset Value(s)
20th May 20265:17 pmRNSMonthly Factsheet as at 30 April 2026
20th May 20263:13 pmRNSNet Asset Value(s)
19th May 20263:02 pmRNSNet Asset Value(s)
18th May 202612:17 pmRNSNet Asset Value(s)
15th May 20264:09 pmRNSNet Asset Value(s)
14th May 202612:47 pmRNSNet Asset Value(s)
13th May 20262:25 pmRNSNet Asset Value(s)
12th May 202611:38 amRNSNet Asset Value(s)
11th May 20261:11 pmRNSNet Asset Value(s)
8th May 202612:46 pmRNSNet Asset Value(s)
7th May 202612:01 pmRNSNet Asset Value(s)
6th May 20263:31 pmRNSNet Asset Value(s)
5th May 202612:39 pmRNSNet Asset Value(s)
1st May 20262:19 pmRNSNet Asset Value(s)
1st May 20269:47 amRNSTotal Voting Rights
30th Apr 202612:30 pmRNSMonthly Factsheet as at 31 March 2026
30th Apr 202611:47 amRNSNet Asset Value(s)
29th Apr 20262:24 pmRNSNet Asset Value(s)
28th Apr 202611:53 amRNSNet Asset Value(s)
27th Apr 202612:18 pmRNSNet Asset Value(s)
24th Apr 20261:16 pmRNSNet Asset Value(s)
23rd Apr 202612:59 pmRNSNet Asset Value(s)
22nd Apr 20263:16 pmRNSNet Asset Value(s)
21st Apr 202611:14 amRNSNet Asset Value(s)
20th Apr 20263:44 pmRNSNet Asset Value(s)
17th Apr 20261:11 pmRNSNet Asset Value(s)
16th Apr 20261:44 pmRNSNet Asset Value(s)
15th Apr 20261:06 pmRNSNet Asset Value(s)
14th Apr 20261:05 pmRNSNet Asset Value(s)
13th Apr 20263:24 pmRNSResult of AGM
13th Apr 202612:21 pmRNSNet Asset Value(s)
10th Apr 20261:07 pmRNSNet Asset Value(s)
9th Apr 20261:35 pmRNSNet Asset Value(s)
8th Apr 20263:29 pmRNSNet Asset Value(s)
7th Apr 20264:49 pmRNSNet Asset Value(s)
1st Apr 20265:13 pmRNSNet Asset Value(s)
1st Apr 20269:37 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.